Eclist - MASSON Editeur

Poster abstracts
7. Therapy symptomatic

P142	The effect of interferon-beta-1B (IFNb-1b) on cognitive functions in multiple sclerosis
P143	The synthetic cannabinoid Nabilone? reduces spasticity in multiple sclerosis
P144	Effect of Betaferon on cognitive function: results of the European trial on secondary progressive Multiple Sclerosis (SPMS)
P145	The effect of inflatable pressure splint (IPS) on patients with multiple sclerosis (MS)
P146	Open, randomized, prospective trial to determine the optimal strategy concerning treatment of influenza-like symptoms during the therapy with interferon beta-1a (Avonex?)
P147	High dose methylprednisolone treatment for multiple sclerosis relapses: correlation between MRI disease activity and cytokines mRNA
P148	A goal-orientated approach to intrathecal baclofen therapy in patients with multiple sclerosis
P149	Modafinil in MS patients with fatigue
P150	Double-blind crossover study with dolasetron mesilate, a 5-HT3 receptor antagonist in patients with cerebellar syndrome secondary of multiple sclerosis
P151	Defining a dose of intravenous immunoglobulin (IVIG) in the treatment of multiple sclerosis
P152	Bladder dysfunction in multiple sclerosis
P153	The density of presumably sensory SP- and CGRP- containing nerve fibers correlates with the functional status of the lower urinary tract in patients with multiple sclerosis. A preliminary study

CONGRES ECTRIMS
6 - 9 septembre 2000
Toulouse